ABCC3 and cancer: Previous studies have shown that the multidrug resistance-associated protein family is closely related to increased drug resistance in patients.[20] Our results showed that higher risk scores were strongly correlated with MRP1 and MRP3 expression, indicating that targeting tumor drug resistance genes may serve as a fundamental approach for patients with cancer.